Data Security Concerns Over Medigen COVID Vaccine Trial

Published

By Damon Lin/Philip Brossard

Taiwanese vaccine maker Medigen is facing scrutiny after it was revealed that a Chinese company may have access to data from a clinical trial for the company’s COVID-19 jab.